Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Jun;5(6):515–521. doi: 10.1111/j.1365-2125.1978.tb01666.x

The use of dobutamine in myocardial infarction for reversal of the cardiodepressive effect of metoprolol.

F Waagstein, I Malek, A C Hjalmarson
PMCID: PMC1429366  PMID: 350252

Abstract

1 Ten patients with acute myocardial infarction were infused dobutamine in increasing doses up to 15 microgram kg--1 min--1. 2 Metoprolol (total dose 15 mg) was then given intravenously to nine of these patients and the beta-adrenoceptor against effects produced by dobutamine were effectively reversed. 3 Nine patients with acute myocardial infarction pretreated with metoprolol (15 mg) were infused dobutamine 15 microgram kg--1 min--1 for 10 min. This resulted in effective reversal of the beta-adrenoceptor antagonist effects induced by metoprolol, without the occurrence of serious arrhythmias or other unwanted effects. 4 Dobutamine may be valuable in counteracting any undesirable cardiodepressive effects of beta-adrenergic receptor blocking drugs (especially the cardioselective agents) in patients with acute myocardial infarction.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beregovich J., Bianchi C., D'Angelo R., Diaz R., Rubler S. Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure. Br Heart J. 1975 Jun;37(6):629–634. doi: 10.1136/hrt.37.6.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hill D. W., Thompson F. D. The effect of haematocrit on the resistivity of human blood at 37 degrees C and 100 kHz. Med Biol Eng. 1975 Mar;13(2):182–186. doi: 10.1007/BF02477725. [DOI] [PubMed] [Google Scholar]
  3. Hill D. W., Thompson F. D. The importance of blood resistivity in the measurement of cardiac output by the thoracic impedance method. Med Biol Eng. 1975 Mar;13(2):187–191. doi: 10.1007/BF02477726. [DOI] [PubMed] [Google Scholar]
  4. Hinds J. E., Hawthorne E. W. Comparative cardiac dynamic effects of dobutamine and isoproterenol in conscious instrumented dogs. Am J Cardiol. 1975 Dec;36(7):894–901. doi: 10.1016/0002-9149(75)90079-x. [DOI] [PubMed] [Google Scholar]
  5. Hochberg H. M., Salomon H. Accuracy of an automated ultrasound blood pressure monitor. Curr Ther Res Clin Exp. 1971 Feb;13(2):129–138. [PubMed] [Google Scholar]
  6. Jewitt D. E., Singh B. N. Special article. The role of beta-adrenergic blockade in myocardial infarction. Prog Cardiovasc Dis. 1974 Jan-Feb;16(4):421–438. doi: 10.1016/0033-0620(74)90032-2. [DOI] [PubMed] [Google Scholar]
  7. Jewitt D., Birkhead J., Mitchell A., Dollery C. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine. Lancet. 1974 Aug 17;2(7877):363–367. doi: 10.1016/s0140-6736(74)91754-1. [DOI] [PubMed] [Google Scholar]
  8. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  9. Mueller H. S., Ayres S. M., Religa A., Evans R. G. Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics. Circulation. 1974 Jun;49(6):1078–1087. doi: 10.1161/01.cir.49.6.1078. [DOI] [PubMed] [Google Scholar]
  10. Naggar C. Z., Dobnik D. B., Flessas A. P., Kripke B. J., Ryan T. J. Accuracy of the stroke index as determined by the transthoracic electrical impedance method. Anesthesiology. 1975 Feb;42(2):201–205. doi: 10.1097/00000542-197502000-00015. [DOI] [PubMed] [Google Scholar]
  11. Talley R. C., Meyer J. F., McNay J. L. Evaluation of the pre-ejection period as an estimate of myocardial contractility in dogs. Am J Cardiol. 1971 Apr;27(4):384–391. doi: 10.1016/0002-9149(71)90435-8. [DOI] [PubMed] [Google Scholar]
  12. Tuttle R. R., Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975 Jan;36(1):185–196. doi: 10.1161/01.res.36.1.185. [DOI] [PubMed] [Google Scholar]
  13. Vatner S. F., McRitchie R. J., Braunwald E. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. J Clin Invest. 1974 May;53(5):1265–1273. doi: 10.1172/JCI107673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Viljoen J. F., Estafanous F. G., Kellner G. A. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg. 1972 Nov;64(5):826–830. [PubMed] [Google Scholar]
  15. WEISSLER A. M., KAMEN A. R., BORNSTEIN R. S., SCHOENFELD C. D., COHEN S. THE EFFECT OF DESLANOSIDE ON THE DURATION OF THE PHASES OF VENTRICULAR SYSTOLE IN MAN. Am J Cardiol. 1965 Feb;15:153–161. doi: 10.1016/0002-9149(65)90449-2. [DOI] [PubMed] [Google Scholar]
  16. Waagstein F., Hjalmarson A. C. Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction. Acta Med Scand Suppl. 1976;587:201–208. doi: 10.1111/j.0954-6820.1976.tb05882.x. [DOI] [PubMed] [Google Scholar]
  17. Waagstein F., Hjalmarson A. C. Effect of cardioselective beta-blockade on heart function and chest pain in acute myocardial infarction. Acta Med Scand Suppl. 1976;587:193–200. doi: 10.1111/j.0954-6820.1976.tb05881.x. [DOI] [PubMed] [Google Scholar]
  18. Waagstein F., Hjalmarson A. C., Wasir H. S. Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol. Br Heart J. 1974 Nov;36(11):1109–1121. doi: 10.1136/hrt.36.11.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES